The Charles LeMoyne Hospital is the major hospital in Longueuil, Quebec, Canada. It is located on Taschereau Boulevard in the borough of Greenfield Park opposite the borough of Saint-Hubert and in close proximity to the LeMoyne neighbourhood in the borough of Le Vieux-Longueuil.

There are 571 beds in Hopital Charles LeMoyne.

During the past decade, Hopital Charles LeMoyne conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 39 clinical trials were completed, i.e. on average, 130% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 14 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Charles LeMoyne" #1 sponsor was "NCIC Clinical Trials Group" with 17 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "Canadian Cancer Trials Group" with 7 trials sponsored, "National Cancer Institute (NCI)" with 7 trials sponsored and "CR-CSSS Champlain-Charles-Le Moyne" with 7 trials sponsored. Other sponsors include 77 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Charles LeMoyne" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NCIC Clinical Trials Group" with 15 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator, "North Central Cancer Treatment Group" with 7 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 100 different institutions and companies that were collaborators in the rest 80 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Charles LeMoyne" are "Breast Cancer" (14 trials), "Colorectal Cancer" (10 trials), "Lymphoma" (7 trials), "Prostate Cancer" (5 trials) and "Chronic Kidney Disease" (4 trials). Many other conditions were trialed in "Hopital Charles LeMoyne" in a lesser frequency.

Most popular intervention types in "Hopital Charles LeMoyne" are "Drug" (99 trials), "Other" (26 trials), "Biological" (16 trials), "Procedure" (14 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (7 trials), "Cyclophosphamide" (6 trials), "Laboratory Biomarker Analysis" (6 trials), "Placebo" (6 trials) and "Quality-of-Life Assessment" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Charles LeMoyne" are 104 trials for "All" genders, 18 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Hopital Charles LeMoyne". 1 are not yet recruiting, 8 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 81 completed trials in Hopital Charles LeMoyne, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Charles LeMoyne, 5 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".